• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Introduction to 8-Oxo-8-(9-phenanthryl)octanoic acid (CAS No. 898766-09-1) and Its Emerging Applications in Chemical Biology

8-Oxo-8-(9-phenanthryl)octanoic acid, identified by the chemical identifier CAS No. 898766-09-1, is a sophisticated organic compound that has garnered significant attention in the field of chemical biology due to its unique structural and functional properties. This compound, featuring a phenanthryl moiety linked to an octanoic acid backbone, exhibits intriguing biochemical characteristics that make it a promising candidate for various research applications. The molecular structure of 8-Oxo-8-(9-phenanthryl)octanoic acid not only contributes to its distinct chemical behavior but also opens up possibilities for its utilization in drug discovery, material science, and other interdisciplinary domains.

The phenanthryl group in 8-Oxo-8-(9-phenanthryl)octanoic acid is a key structural feature that imparts specific electronic and steric properties to the molecule. Phenanthryl derivatives are well-known for their ability to interact with biological targets due to their aromaticity and planarity, which facilitate binding to proteins and enzymes. In recent years, there has been a surge in research focusing on the development of phenanthryl-based compounds as pharmacophores, owing to their potential in modulating biological pathways. The incorporation of the octanoic acid moiety further enhances the compound's solubility and bioavailability, making it more suitable for in vivo studies.

One of the most compelling aspects of 8-Oxo-8-(9-phenanthryl)octanoic acid is its potential application in the development of novel therapeutic agents. The compound's ability to interact with biological macromolecules has led researchers to explore its role in inhibiting key enzymes involved in metabolic disorders, cancer, and inflammation. For instance, studies have suggested that derivatives of 8-Oxo-8-(9-phenanthryl)octanoic acid may exhibit inhibitory effects on enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are pivotal in mediating inflammatory responses. These findings have sparked interest in leveraging this compound as a lead molecule for drug design.

Moreover, the structural versatility of 8-Oxo-8-(9-phenanthryl)octanoic acid has opened up avenues for its use in material science applications. The compound's aromatic core and flexible octanoic acid side chain make it an excellent candidate for designing functional materials with tailored properties. Researchers have been exploring its potential as a building block for organic semiconductors, luminescent materials, and polymer additives. The ability of 8-Oxo-8-(9-phenanthryl)octanoic acid to self-assemble into ordered structures has also been investigated, paving the way for applications in nanotechnology and supramolecular chemistry.

In the realm of chemical biology, 8-Oxo-8-(9-phenanthryl)octanoic acid has been utilized as a tool compound for studying protein-ligand interactions. The phenanthryl group serves as a recognition element that can be engineered to target specific binding sites on proteins. This has enabled researchers to develop high-affinity probes for biomarker detection and to dissect complex signaling pathways. The compound's fluorescence properties have also been harnessed for imaging applications, allowing for real-time visualization of biological processes at the cellular level.

The synthesis of 8-Oxo-8-(9-phenanthryl)octanoic acid presents an intriguing challenge due to its complex structure. However, advances in synthetic methodologies have made it more accessible than ever before. Modern techniques such as palladium-catalyzed cross-coupling reactions and directed ortho-metalation strategies have enabled chemists to construct the phenanthryl core with high precision. These synthetic advancements have not only facilitated the production of pure samples of 8-Oxo-8-(9-phenanthryl)octanoic acid but also allowed for the introduction of diverse functional groups, enhancing its utility in various applications.

Recent studies have highlighted the potential of 8-Oxo-8-(9-phenanthryl)octanoic acid in modulating cellular processes through its interaction with nuclear receptors. Nuclear receptors are transcription factors that play a crucial role in regulating gene expression in response to environmental signals. By binding to these receptors, 8-Oxo-8-(9-phenanthryl)octanoic acid can influence pathways involved in lipid metabolism, inflammation, and cancer progression. This has led to investigations into its potential as an agonist or antagonist for nuclear receptor targets, opening up new therapeutic possibilities.

The pharmacokinetic properties of 8-Oxo-8-(9-phenanthryl)octanoic acid are another area of active research. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for optimizing its therapeutic efficacy and safety profile. Preclinical studies have begun to unravel these aspects, providing valuable insights into dosing regimens and potential side effects. These studies are critical for translating laboratory findings into clinical applications and ensuring that 8-Oxo-8-(9-phenanthlyloctanoic acid) can be developed into a viable drug candidate.

In conclusion, ightened by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by its unique structural features, ighlighted by Its emerging applications underscore why it is considered a significant compound in modern chemical biology research.

• 2051-95-8(3-Benzoylpropionic acid)
• 64779-08-4(4-(4-Hexylphenyl)-4-oxobutyric acid)
• 4619-20-9(4-(4-Methylphenyl)-4-oxobutanoic Acid)
• 66147-75-9(7-Oxo-8-phenyloctanoic Acid)
• 1501-05-9(5-Oxo-5-phenylpentanoic acid)
• 1590-22-3(3-(2-Naphthoyl)propionic Acid)
• 6336-53-4(4,7-Dioxo-7-phenylheptanoic Acid)
• 7472-43-7(7-Oxo-7-phenylheptanoic acid)
• 49594-75-4(4-Ethyl-γ-oxobenzenebutanoic Acid)
• 4144-62-1(5-Benzoylpentanoic acid)